Competition is high, and a few stemcell companies have pivoted into exosomes.
What makes EX1 different though is that they are creating the pickaxes of actually creating the exosomes. Others will be the miners and make them into useful biologics. EX1 is helping to do that with their studies, but I think it is a play to make the space bigger for them supplying everyone with the exosomes.
